反応式
[CH3:1][N:2]([CH3:15])[C:3]1[C:12]2[C:7](=[CH:8][CH:9]=[C:10]([CH:13]=O)[CH:11]=2)[N:6]=[CH:5][N:4]=1.[NH:16]=[C:17]1[NH:21][C:20](=[O:22])[CH2:19][S:18]1>>[NH:16]=[C:17]1[NH:21][C:20](=[O:22])[C:19](=[CH:13][C:10]2[CH:11]=[C:12]3[C:7](=[CH:8][CH:9]=2)[N:6]=[CH:5][N:4]=[C:3]3[N:2]([CH3:15])[CH3:1])[S:18]1参加物
3
実験手順
Following the general method as outlined in Example 1, starting from 4-piperidine-quinazoline-6-carbaldehyde (intermediate 14) and 2-imino-1,3-thiazolidin-4-one, the title compound was obtained.
出典と根拠
- ORDレコード
- ord-7796b2709bf24bc1a3c00daa103a756d
- 出典データセット
- uspto-grants-2010_12
- 特許番号
- US07846925B2
関連ノート
読み込み中…